Filamentous fungal mutants with improved homologous recombination efficiency
AssigneeDsm IP Assets B.V.
InventorsPetrus Jacobus Theodorus Dekker, Marco Alexander van den Berg
Life of this patent
Estimating the term…
Loading patent…
AssigneeDsm IP Assets B.V.
InventorsPetrus Jacobus Theodorus Dekker, Marco Alexander van den Berg
Estimating the term…
The present invention relates to a method for increasing the efficiency of targeted integration of a polynucleotide to a pre-determined site into the genome of a filamentous fungal cell with a preference for NHR, wherein said polynucleotide has a region of homology with said pre-determined site, comprising steering an integration pathway towards HR. The present invention also relates to a mutant filamentous fungus originating from a parent cell, said mutant having an HR pathway with elevated efficiency and/or an NHR pathway with a lowered efficiency and/or a NHR/HR ratio with decreased efficiency as compared to said HR and/or NHR efficiency and/or NHR/HR ratio of said parent cell under the same conditions.
Method for increasing the efficiency of targeted integration of a polynucleotide to a pre-determined site into the genome of a filamentous fungal cell with a preference for NHR, wherein said polynucleotide has a region of homology with said pre-determined site, wherein said filamentous fungal cell belongs the genus Penicillium, comprising providing a mutant of a parent filamentous fungal cell, wherein the ratio of NHR/HR is decreased in the mutant as compared to said ratio in said parent organism measured under the same conditions, wherein said mutant is deficient in a gene encoding a component involved in NHR, and/or has a decreased level of a component involved in NHR.
A mutant of a parent filamentous fungal cell, the parent organism having a preference for NHR, wherein the filamentous fungal host cell is a Penicillium species, wherein the ratio of NHR/HR is decreased in the mutant as compared to said ratio in said parent organism measured under the same conditions, wherein the mutant is deficient in a gene encoding a component involved in NHR, and/or has a decreased level of a component involved in NHR.
Dependencies are inferred from the claim text.